Meeting
2020 ASCO Virtual Scientific Program
Comparative effectiveness of systemic treatments for metastatic castration-sensitive prostate cancer: A parametric survival network meta-analysis of randomized controlled trials.
Authors
Lin Wang
Johns Hopkins School of Public Health, Baltimore, MD
Lin Wang , Channing Judith Paller , Hwanhee Hong , Anthony De Felice , Caleb Alexander , Otis W. Brawley
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 38: 2020 (suppl; abstr 5532)
DOI
10.1200/JCO.2020.38.15_suppl.5532
Abstract #
5532
Poster Bd #
113
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Comparative survival in metastatic castration-sensitive prostate cancer (mCSPC) by prognostic subgroups: A living network meta-analysis.
First Author: Syed Arsalan Ahmed Naqvi
Poster
2023 ASCO Genitourinary Cancers Symposium
Survival outcomes in metastatic castration-resistant prostate cancer in the up-front treatment era.
First Author: Shunsuke Kamijo
Poster
2023 ASCO Annual Meeting
The role of volume of disease for treatment selection in patients with metastatic castration sensitive prostate cancer (mCSPC): A living meta-analysis.
First Author: Syed Arsalan Ahmed Naqvi
Poster
2022 ASCO Genitourinary Cancers Symposium
Practice patterns in the management of metastatic castration-sensitive prostate cancer: A single-center survey-based study.
First Author: Eric Lu